APA (7th ed.) Citation

ML, R., MD, E., CS, B., A, R., & IR, C. (2024). PCSK9 Inhibitors and Anthracyclines: The Future of Cardioprotection in Cardio-Oncology. Hearts (Basel, Switzerland), 5(3), 375. https://doi.org/10.3390/hearts5030027

Chicago Style (17th ed.) Citation

ML, Repp, Edwards MD, Burch CS, Rao A, and Chinyere IR. "PCSK9 Inhibitors and Anthracyclines: The Future of Cardioprotection in Cardio-Oncology." Hearts (Basel, Switzerland) 5, no. 3 (2024): 375. https://doi.org/10.3390/hearts5030027.

MLA (9th ed.) Citation

ML, Repp, et al. "PCSK9 Inhibitors and Anthracyclines: The Future of Cardioprotection in Cardio-Oncology." Hearts (Basel, Switzerland), vol. 5, no. 3, 2024, p. 375, https://doi.org/10.3390/hearts5030027.